SARS CoV-2 Pathogenesis and Immune Response

被引:0
作者
Dinc, Harika Oyku [1 ]
Yuksel Mayda, Pelin [1 ]
机构
[1] Bezmialem Vakif Univ, Dept Pharmaceut Microbiol, Fac Pharm, Istanbul, Turkey
来源
BEZMIALEM SCIENCE | 2020年 / 8卷
关键词
Coronavirus; COVID-19; pathogenesis; immunology; SARS-CoV-2; CLINICAL CHARACTERISTICS; COVID-19;
D O I
10.14235/bas.galenos.2020.4776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The agent responsible for the epidemic that first appeared in Wuhan, China, in December 2019 was detected to be the new coronavirus (2019-nCoV). Later, the virus that caused respiratory tract infection was discovered to be a member of the beta-coronavirus family, it was named as severe acute respiratory syndrome-CoV2 (SARS-CoV 2), and the disease it caused was called CoV infection disease-19 (COVID-19). The epidemic started in China, spread rapidly first to East Asian countries, then Europe and America, affected the whole world, and was declared a pandemic by the World Health Organization. This review presents an overview of SARS-CoV2 and aims to examine its intracellular pathogenesis and host immune responses.
引用
收藏
页码:153 / 156
页数:4
相关论文
共 31 条
[1]  
Abbas A., 2014, Basic Immunology
[2]  
Abbas A., 2010, CELL MOL IMMUNOL
[3]   Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response [J].
Astuti, Indwiani ;
Ysrafil .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) :407-412
[4]   COVID-19: immunopathology and its implications for therapy [J].
Cao, Xuetao .
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (05) :269-270
[5]   Clinical and immunological features of severe and moderate coronavirus disease 2019 [J].
Chen, Guang ;
Wu, Di ;
Guo, Wei ;
Cao, Yong ;
Huang, Da ;
Wang, Hongwu ;
Wang, Tao ;
Zhang, Xiaoyun ;
Chen, Huilong ;
Yu, Haijing ;
Zhang, Xiaoping ;
Zhang, Minxia ;
Wu, Shiji ;
Song, Jianxin ;
Chen, Tao ;
Han, Meifang ;
Li, Shusheng ;
Luo, Xiaoping ;
Zhao, Jianping ;
Ning, Qin .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) :2620-2629
[6]   The Rheumatologist's Role in COVID-19 [J].
Cron, Randy Q. ;
Chatham, W. Winn .
JOURNAL OF RHEUMATOLOGY, 2020, 47 (05) :639-642
[7]  
Doan T, 2017, LIPPINCOTTS ILLUSTRA
[8]  
Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
[9]   COVID-19: Immunology and treatment options [J].
Felsenstein, Susanna ;
Herbert, Jenny A. ;
McNamara, Paul S. ;
Hedrich, Christian M. .
CLINICAL IMMUNOLOGY, 2020, 215
[10]   Hemophagocytic lymphohistiocytosis: review of etiologies and management [J].
George, Melissa R. .
JOURNAL OF BLOOD MEDICINE, 2014, 5 :69-86